Fundraising FoxOrion Biotechnology
1 known investors
Find your way into Orion Biotechnology
Sign up to see every warm intro you have to Orion Biotechnology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Orion Biotechnology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Orion Biotechnology is a biotech company developing GPCR-targeted therapeutics for obesity and metabolic disorders, with preclinical candidates against targets including GPR75, GIPR, and amylin. It operates a proprietary drug discovery platform designed to shorten GPCR discovery campaigns and pursues out-licensing and R&D collaborations.
Founders & leadership
PT
Praveen TyleCEO
AK
Anatole KlepatskyChief Business Officer
OH
Oliver HartleyVice President, Drug Discovery
Investors · 1
Frequently asked questions
- What does Orion Biotechnology do?
- Orion Biotechnology is a biotech company developing GPCR-targeted therapeutics for obesity and metabolic disorders, with preclinical candidates against targets including GPR75, GIPR, and amylin. It operates a proprietary drug discovery platform designed to shorten GPCR discovery campaigns and pursues out-licensing and R&D collaborations.
- Who are Orion Biotechnology's investors?
- Orion Biotechnology's investors include Globivest.